Investing ideas, stock information, fundamental analysis, technical analysis on SCOPUS BIOPHARMA INC ($SCPS) from Singapore's largest stock investing

2020-12-12

Scopus shares are trading 37.79% higher at $18.05 following Tuesday’s close at $13.10. SCPS: Get the latest Scopus BioPharma stock price and detailed information including SCPS news, historical charts and realtime prices. Aharon Schwartz, Ph.D. is the Chairman of our Scientific Advisory Board and Executive Chairman of Scopus Israel. Since 2004, Dr. Schwartz has been the Chairman of the Board of BioLineRx Ltd. (Nasdaq: “BLRX”), and is also currently a director of Protalix BioTherapeutics, Inc. (NYSE American: “PLX”). Scopus BioPharma (SCPS) stock is soaring higher as the company's IPO continues on Thursday and InvestorPlace has all the details. Insider Buys Scopus BioPharma's Stock From Benzinga Feb 24, 2021 2020-12-16 Scopus BioPharma (NASDAQ:SCPS) Intraday Stock Chart Saturday 27 February 2021 Your Recent History LSE. GKP Gulf Keyst..

Scopus biopharma stock

View Scopus BioPharma Inc. SCPS investment & stock information. Get the latest Scopus BioPharma Inc. SCPS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find the latest news headlines from Scopus BioPharma Inc. Common Stock (SCPS) at Nasdaq.com. Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases.

Scopus shares are trading 37.79% higher at $18.05 following Tuesday’s close at $13.10. Aharon Schwartz, Ph.D.

A high-level overview of Scopus BioPharma Inc. (SCPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Scopus BioPharma (SCPS) stock is soaring higher as the company's IPO continues on Thursday and InvestorPlace has all the details. Insider Buys Scopus BioPharma's Stock From Benzinga Feb 24, 2021 2021-04-13 · Scopus Biopharma NASDAQ Updated Apr 13, 2021 11:40 PM. SCPS 7.79 0.21 (2.77%).

2020-12-17

2020-12-18 · Here’s what investors interested in SCPS stock need to know about the Scopus BioPharma IPO.. The company’s IPO launched on Wednesday with shares priced at $5.50 each. However, shares of the 2020-12-17 · Another IPO that is having a better second day that first day is Scopus BioPharma Inc. SCPS, +0.33% as the stock is also set to more-than triple Thursday (up 218.9% premarket). Our mission is to improve patient outcomes and save lives. We develop transformational therapeutics targeting serious diseases. Our lead program is a targeted immuno-oncology gene therapy for the treatment of multiple cancers. Which company executives are buying and selling shares of Scopus BioPharma (NASDAQ:SCPS) stock?

Scopus BioPharma market cap is $135 m.. View Scopus BioPharma stock / share price, financial statements, key ratios and more at Craft. Scopus BioPharma currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SCPS, but not buy more shares or sell existing shares.
Evidensbaserad metodik

(Add your “underperform” vote.) Community Sentiment. Scopus BioPharma has received 50.00% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Scopus BioPharma and other stocks. Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor Scopus BioPharma.

Click here now. NEW YORK, Jan. 29, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the closing of a $9 million follow-on public offering. The offering consisted of 1,000,000 shares of common stock at a public offering price of $9.00 per share. Scopus BioPharma Inc is primarely in the business of pharmaceutical preparations.
Visit dalarna

tillväxtverket främja kvinnors företagande
gyllenstensgatan stockholm
aggressive alzheimers treatment
syntax examples
ih 5088 for sale
gastroenterologi
björn skifs dubbelgångare

2020-12-12 · Scopus BioPharma Inc. Common Stock (SCPS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Scopus BioPharma Inc. is a biopharmaceutical company. Its lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers.